Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 1 AL 15

Comparative analysis of the Alzheimer questionnaire (AQ) with the CDR sum of boxes, MoCA, and MMSE

Malek-Ahmadi M, Davis K, Belden CM, Sabbagh MN.

Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):296-8. doi: 10.1097/WAD.0b013e3182769731.

Facilitating the use of implicit memory and learning in the physical therapy management of individuals with Alzheimer disease: a case series

White L, Ford MP, Brown CJ, Peel C, Triebel KL.

J Geriatr Phys Ther. 2014 Jan-Mar;37(1):35-44. doi: 10.1519/JPT.0b013e3182862d2c.

Curcumin and curcumin-like molecules: from spice to drugs

Marchiani A, Rozzo C, Fadda A, Delogu G, Ruzza P.

Curr Med Chem. 2014;21(2):204-22. doi: 10.2174/092986732102131206115810.

Inhibition of amyloid-β aggregation in Alzheimer's disease

Wang Q, Yu X, Li L, Zheng J.

Curr Pharm Des. 2014;20(8):1223-43. doi: 10.2174/13816128113199990068.

Disruption of zinc neuromodulation by Aß oligomers: therapeutic implications

Vogler EC, Busciglio J.

Curr Pharm Des. 2014;20(15):2520-4. doi: 10.2174/13816128113199990510.

The effects of soluble Aβ oligomers on neurodegeneration in Alzheimer's disease

Brouillette J.

Curr Pharm Des. 2014;20(15):2506-19. doi: 10.2174/13816128113199990498.

In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches

Balducci C, Forloni G.

Curr Pharm Des. 2014;20(15):2491-505. doi: 10.2174/13816128113199990497.

Getting rid of intracellular Aβ- loss of cellular degradation leads to transfer between connected neurons

Agholme L, Hallbeck M.

Curr Pharm Des. 2014;20(15):2458-68. doi: 10.2174/13816128113199990501.

The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease

Lynch MA.

Immunology. 2014 Mar;141(3):292-301. doi: 10.1111/imm.12156.

Hippocampal neurogenesis in Alzheimer's disease: is there a role for dietary modulation?

Maruszak A, Pilarski A, Murphy T, Branch N, Thuret S.

J Alzheimers Dis. 2014;38(1):11-38. doi: 10.3233/JAD-131004.

Cellular prion protein as a therapeutic target in Alzheimer's disease

Laurén J.

J Alzheimers Dis. 2014;38(2):227-44. doi: 10.3233/JAD-130950.

Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination

van Wijk N, Broersen LM, de Wilde MC, Hageman RJ, Groenendijk M, Sijben JW, Kamphuis PJ.

J Alzheimers Dis. 2014;38(3):459-79. doi: 10.3233/JAD-130998.

Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemic ammonia and erythrocyte energy metabolism

Kosenko EA, Solomadin IN, Tikhonova LA, Reddy VP, Aliev G, Kaminsky YG.

CNS Neurol Disord Drug Targets. 2014 Feb;13(1):112-9. doi: 10.2174/18715273113126660130.

Alzheimer´s disease and oxidative stress: a review

Pohanka M.

Curr Med Chem. 2014;21(3):356-64. doi: 10.2174/09298673113206660258.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias